FDA Inspection 1227201 — Reproductive Medicine Associates Of Philadelphia
The FDA completed an inspection of Reproductive Medicine Associates Of Philadelphia on Dec 7, 2023 in King of Prussia, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 7, 2023
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- King of Prussia, PA (United States)